Literature DB >> 27623307

Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models.

Justin K Mikell1, Armeen Mahvash2, Wendy Siman1, Veera Baladandayuthapani3, Firas Mourtada4, S Cheenu Kappadath5.   

Abstract

PURPOSE: To quantify differences that exist between dosimetry models used for 90Y selective internal radiation therapy (SIRT). METHODS AND MATERIALS: Retrospectively, 37 tumors were delineated on 19 post-therapy quantitative 90Y single photon emission computed tomography/computed tomography scans. Using matched volumes of interest (VOIs), absorbed doses were reported using 3 dosimetry models: glass microsphere package insert standard model (SM), partition model (PM), and Monte Carlo (MC). Univariate linear regressions were performed to predict mean MC from SM and PM. Analysis was performed for 2 subsets: cases with a single tumor delineated (best case for PM), and cases with multiple tumors delineated (typical clinical scenario). Variability in PM from the ad hoc placement of a single spherical VOI to estimate the entire normal liver activity concentration for tumor (T) to nontumoral liver (NL) ratios (TNR) was investigated. We interpreted the slope of the resulting regression as bias and the 95% prediction interval (95%PI) as uncertainty. MCNLsingle represents MC absorbed doses to the NL for the single tumor patient subset; other combinations of calculations follow a similar naming convention.
RESULTS: SM was unable to predict MCTsingle or MCTmultiple (p>.12, 95%PI >±177 Gy). However, SMsingle was able to predict (p<.012) MCNLsingle, albeit with large uncertainties; SMsingle and SMmultiple yielded biases of 0.62 and 0.71, and 95%PI of ±40 and ± 32 Gy, respectively. PMTsingle and PMTmultiple predicted (p<2E-6) MCTsingle and MCTmultiple with biases of 0.52 and 0.54, and 95%PI of ±38 and ± 111 Gy, respectively. The TNR variability in PMTsingle increased the 95%PI for predicting MCTsingle (bias = 0.46 and 95%PI = ±103 Gy). The TNR variability in PMTmultiple modified the bias when predicting MCTmultiple (bias = 0.32 and 95%PI = ±110 Gy).
CONCLUSIONS: The SM is unable to predict mean MC tumor absorbed dose. The PM is statistically correlated with mean MC, but the resulting uncertainties in predicted MC are large. Large differences observed between dosimetry models for 90Y SIRT warrant caution when interpreting published SIRT absorbed doses. To reduce uncertainty, we suggest the entire NL VOI be used for TNR estimates when using PM.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27623307      PMCID: PMC5085875          DOI: 10.1016/j.ijrobp.2016.07.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

1.  Introduction.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1995-04       Impact factor: 5.934

Review 2.  Radioembolization dosimetry: the road ahead.

Authors:  Maarten L J Smits; Mattijs Elschot; Daniel Y Sze; Yung H Kao; Johannes F W Nijsen; Andre H Iagaru; Hugo W A M de Jong; Maurice A A J van den Bosch; Marnix G E H Lam
Journal:  Cardiovasc Intervent Radiol       Date:  2014-12-24       Impact factor: 2.740

3.  Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.

Authors:  Harun Ilhan; Anna Goritschan; Philipp Paprottka; Tobias F Jakobs; Wolfgang P Fendler; Andrei Todica; Peter Bartenstein; Marcus Hacker; Alexander R Haug
Journal:  J Nucl Med       Date:  2015-08-27       Impact factor: 10.057

4.  Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.

Authors:  Arnaud Dieudonné; Etienne Garin; Sophie Laffont; Yan Rolland; Rachida Lebtahi; Dominique Leguludec; Isabelle Gardin
Journal:  J Nucl Med       Date:  2011-11-08       Impact factor: 10.057

5.  Development and evaluation of an improved quantitative (90)Y bremsstrahlung SPECT method.

Authors:  Xing Rong; Yong Du; Michael Ljungberg; Erwann Rault; Stefaan Vandenberghe; Eric C Frey
Journal:  Med Phys       Date:  2012-05       Impact factor: 4.071

6.  (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres.

Authors:  Mattijs Elschot; Johannes F W Nijsen; Marnix G E H Lam; Maarten L J Smits; Jip F Prince; Max A Viergever; Maurice A A J van den Bosch; Bernard A Zonnenberg; Hugo W A M de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-13       Impact factor: 9.236

7.  Quantitative Monte Carlo-based 90Y SPECT reconstruction.

Authors:  Mattijs Elschot; Marnix G E H Lam; Maurice A A J van den Bosch; Max A Viergever; Hugo W A M de Jong
Journal:  J Nucl Med       Date:  2013-08-01       Impact factor: 10.057

8.  Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

Authors:  C Chiesa; M Mira; M Maccauro; C Spreafico; R Romito; C Morosi; T Camerini; M Carrara; S Pellizzari; A Negri; G Aliberti; C Sposito; S Bhoori; A Facciorusso; E Civelli; R Lanocita; B Padovano; M Migliorisi; M C De Nile; E Seregni; A Marchianò; F Crippa; V Mazzaferro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-27       Impact factor: 9.236

9.  Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.

Authors:  Etienne Garin; Yan Rolland; Julien Edeline; Nicolas Icard; Laurence Lenoir; Sophie Laffont; Habiba Mesbah; Mathias Breton; Laurent Sulpice; Karim Boudjema; Tanguy Rohou; Jean-Luc Raoul; Bruno Clement; Eveline Boucher
Journal:  J Nucl Med       Date:  2015-02-12       Impact factor: 10.057

Review 10.  Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.

Authors:  Marta Cremonesi; Carlo Chiesa; Lidia Strigari; Mahila Ferrari; Francesca Botta; Francesco Guerriero; Concetta De Cicco; Guido Bonomo; Franco Orsi; Lisa Bodei; Amalia Di Dia; Chiara Maria Grana; Roberto Orecchia
Journal:  Front Oncol       Date:  2014-08-19       Impact factor: 6.244

View more
  8 in total

1.  Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.

Authors:  Riad Salem; Siddharth A Padia; Marnix Lam; Jon Bell; Carlo Chiesa; Kirk Fowers; Bonnie Hamilton; Joseph Herman; S Cheenu Kappadath; Thomas Leung; Lorraine Portelance; Daniel Sze; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-16       Impact factor: 9.236

Review 2.  Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?

Authors:  Eugene J Koay; Bruno C Odisio; Milind Javle; Jean-Nicolas Vauthey; Christopher H Crane
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

3.  Impact of 90Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization.

Authors:  Justin K Mikell; Ravi K Kaza; Peter L Roberson; Kelly C Younge; Ravi N Srinivasa; Bill S Majdalany; Kyle C Cuneo; Dawn Owen; Theresa Devasia; Matthew J Schipper; Yuni K Dewaraja
Journal:  EJNMMI Phys       Date:  2018-11-30

4.  Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization.

Authors:  Isabel Schobert; Julius Chapiro; Nariman Nezami; Charlie A Hamm; Bernhard Gebauer; MingDe Lin; Jeffrey Pollak; Lawrence Saperstein; Todd Schlachter; Lynn J Savic
Journal:  J Nucl Med       Date:  2019-01-17       Impact factor: 10.057

5.  Role of nanoparticles in transarterial radioembolization with glass microspheres.

Authors:  Asra Sadat Talebi; Hossein Rajabi; Hiroshi Watabe
Journal:  Ann Nucl Med       Date:  2022-02-23       Impact factor: 2.258

6.  Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?

Authors:  Verónica Morán; Elena Prieto; Lidia Sancho; Macarena Rodríguez-Fraile; Leticia Soria; Arantxa Zubiria; Josep M Martí-Climent
Journal:  EJNMMI Phys       Date:  2020-12-07

7.  Y-90 SIRT: evaluation of TCP variation across dosimetric models.

Authors:  Benjamin J Van; Yuni K Dewaraja; Mamadou L Sangogo; Justin K Mikell
Journal:  EJNMMI Phys       Date:  2021-06-10

Review 8.  The physics of radioembolization.

Authors:  Remco Bastiaannet; S Cheenu Kappadath; Britt Kunnen; Arthur J A T Braat; Marnix G E H Lam; Hugo W A M de Jong
Journal:  EJNMMI Phys       Date:  2018-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.